23andMe’s Wojcicki Assists Covid-19 Fight With Analytics

23andMe CEO Wojcicki on Telehealth, Covid ResearchПодробнее

23andMe CEO 'Enthused' About Potential Covid VaccinesПодробнее

23andMe CEO Says Covid Pandemic Spurred GrowthПодробнее

#InChargeAtHome with 23andMe Founder Anne Wojcicki and Diane von FurstenbergПодробнее

23andMe studies genetics for clues to COVID-19 severityПодробнее

23andMe Says People With Type O Blood Less Likely Get Covid-19Подробнее

23andMe CEO on Covid-19 study findings and the future of the companyПодробнее

23andMe Using Database Analytics to Track Covid SpreadПодробнее

How 23andMe Is Studying Role Genetics Might Play In COVID-19 | TODAYПодробнее

23andMe CEO talks privacy, personalized medicine, and how genetics can help predict diseaseПодробнее

23andMe CEO Is Happy to be Done With SPAC ProcessПодробнее

The US Has Fallen Far Behind in Genomics: WojcickiПодробнее

23andMe CEO on coronavirus genetic testПодробнее

Healthcare is still ‘stuck in a world of white coats’: 23andMe CEOПодробнее

23 Minutes With Anne, LIVE! Research EditionПодробнее

23andMe Finds New Genetic Links to Covid-19 Loss of Smell SymptomПодробнее

23andMe CEO on public debut, future of genetic testingПодробнее

Benefiting from the Human Genome | Anne Wojcicki || Radcliffe InstituteПодробнее

Anne Wojcicki On The Trials Of Building 23andMe And Leading A Company During The COVID EraПодробнее